ALAMEDA, Calif., Sept. 17, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and CEO Kenneth Chahine will present information on Avigen’s development programs and product pipeline at the UBS 2008 Global Life Sciences Conference. Dr. Chahine will present on Wednesday, September 24, 2008, from 8:30-8:55 a.m. (ET) at the Grand Hyatt Hotel in New York City.
